Applicant, as named in the Orange Book

Vertex Pharms Inc

Next listed expiry: Orkambi on 11 Jun 2031. 8 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Orkambi · 3 strengths ivacaftor; lumacaftor	ivacaftor; lumacaftor	211358	11 Jun 2031	patent
Orkambi · 2 strengths ivacaftor; lumacaftor	ivacaftor; lumacaftor	206038	11 Jun 2031	patent
Kalydeco · 5 strengths ivacaftor	ivacaftor	207925	27 Aug 2033	patent
Symdeko (Copackaged) · 2 strengths ivacaftor; ivacaftor, tezacaftor	ivacaftor; ivacaftor, tezacaftor	210491	14 Apr 2035	patent
Trikafta (Copackaged) · 2 strengths elexacaftor, ivacaftor, tezacaftor; ivacaftor	elexacaftor, ivacaftor, tezacaftor; ivacaftor	217660	8 Dec 2037	patent, carve-out possible
Trikafta (Copackaged) · 2 strengths elexacaftor, ivacaftor, tezacaftor; ivacaftor	elexacaftor, ivacaftor, tezacaftor; ivacaftor	212273	17 Jul 2038	patent, carve-out possible
Alyftrek · 2 strengths deutivacaftor; tezacaftor; vanzacaftor calcium	deutivacaftor; tezacaftor; vanzacaftor calcium	218730	13 Aug 2040	patent, carve-out possible
Journavx suzetrigine	suzetrigine	219209	4 Dec 2040	patent